- Home
- POLA vs BRTX Comparison
POLA vs BRTX Comparison
Compare POLA & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POLA
- BRTX
- Stock Information
- Founded
- POLA 1979
- BRTX 1997
- Country
- POLA United States
- BRTX United States
- Employees
- POLA N/A
- BRTX N/A
- Industry
- POLA Industrial Machinery/Components
- BRTX Managed Health Care
- Sector
- POLA Miscellaneous
- BRTX Health Care
- Exchange
- POLA Nasdaq
- BRTX Nasdaq
- Market Cap
- POLA 11.5M
- BRTX 12.8M
- IPO Year
- POLA 2016
- BRTX N/A
- Fundamental
- Price
- POLA $3.35
- BRTX $1.36
- Analyst Decision
- POLA
- BRTX
- Analyst Count
- POLA 0
- BRTX 0
- Target Price
- POLA N/A
- BRTX N/A
- AVG Volume (30 Days)
- POLA 882.9K
- BRTX 296.8K
- Earning Date
- POLA 11-14-2025
- BRTX 11-12-2025
- Dividend Yield
- POLA N/A
- BRTX N/A
- EPS Growth
- POLA N/A
- BRTX N/A
- EPS
- POLA N/A
- BRTX N/A
- Revenue
- POLA $11,967,000.00
- BRTX $605,200.00
- Revenue This Year
- POLA N/A
- BRTX $232.67
- Revenue Next Year
- POLA N/A
- BRTX $52.92
- P/E Ratio
- POLA N/A
- BRTX N/A
- Revenue Growth
- POLA 0.14
- BRTX 247.62
- 52 Week Low
- POLA $1.53
- BRTX $1.19
- 52 Week High
- POLA $5.75
- BRTX $2.55
- Technical
- Relative Strength Index (RSI)
- POLA 43.67
- BRTX 31.69
- Support Level
- POLA $3.48
- BRTX $1.44
- Resistance Level
- POLA $4.25
- BRTX $1.55
- Average True Range (ATR)
- POLA 0.44
- BRTX 0.09
- MACD
- POLA -0.10
- BRTX -0.03
- Stochastic Oscillator
- POLA 3.69
- BRTX 10.53
About POLA Polar Power Inc.
Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Asia, Europe and Middle East, United Kingdom, Other North America, South Africa, and others.
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.